Scholarlink

<p>The study by Kimoto et al. investigated the relationship between metabolic syndrome (MetS) and breast cancer incidence in a large Japanese cohort exceeding one million women, revealing an unexpected age-dependent pattern. Both pre-MetS and MetS were associated with a lower incidence of breast cancer, particularly in women younger than 50 years, whereas this association attenuated or reversed after 60 years of age. In our correspondence, we discuss potential biological and methodological explanations for this paradox. We highlight the importance of heterogeneity in MetS definitions (Japanese vs. modified ATP III), the role of menopausal status beyond chronological age, and possible confounding by screening behavior and competing cardiovascular mortality. While the authors’ interpretation involving anovulatory cycles and adipose-derived estrogen provides a plausible mechanistic framework, we emphasize the need for analyses stratified by actual menopausal status, repeated measures of MetS components, and competing-risk modeling. Overall, the findings underscore the complex, age-modulated interaction between metabolic dysregulation and breast carcinogenesis, reinforcing the necessity of menopause-specific risk assessment and standardized MetS definitions in future research.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metabolic Syndrome and Breast Cancer Risk: an Age-Dependent Paradox?

  • 期刊论文

  • 发表日期：

    2025年10月28日

查看全文
  • Deniz Esin Tekcan Sanli,
  • Ahmet Necati Sanli

摘要

The study by Kimoto et al. investigated the relationship between metabolic syndrome (MetS) and breast cancer incidence in a large Japanese cohort exceeding one million women, revealing an unexpected age-dependent pattern. Both pre-MetS and MetS were associated with a lower incidence of breast cancer, particularly in women younger than 50 years, whereas this association attenuated or reversed after 60 years of age. In our correspondence, we discuss potential biological and methodological explanations for this paradox. We highlight the importance of heterogeneity in MetS definitions (Japanese vs. modified ATP III), the role of menopausal status beyond chronological age, and possible confounding by screening behavior and competing cardiovascular mortality. While the authors’ interpretation involving anovulatory cycles and adipose-derived estrogen provides a plausible mechanistic framework, we emphasize the need for analyses stratified by actual menopausal status, repeated measures of MetS components, and competing-risk modeling. Overall, the findings underscore the complex, age-modulated interaction between metabolic dysregulation and breast carcinogenesis, reinforcing the necessity of menopause-specific risk assessment and standardized MetS definitions in future research.